Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Top Healthcare M&A Deals of Q1:26
In the first quarter of 2026, investors and dealmakers have announced a total of 549 healthcare transactions, a small increase over volume in Q4:25, according to LevinPro HC’s upcoming quarterly Health Care M&A Report. Below, we’ve highlighted several notable deals that stood out to our editorial team. Boston Scientific Corp.’s purchase of Penumbra, Inc. On January 15, Boston Scientific announced that it was acquiring Penumbra, Inc., for $14.5 billion, marking the largest deal of the year so far. Penumbra is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism and acute limb ischemia. Its... Read More »
Sidelined Capital: A Healthcare Webinar Wrap Up
Earlier in March, Ben Swett, Managing Editor of The SeniorCare Investor, was joined by John Tiedmann, Managing Director at Physician Growth Partners, Bill Hoffman, Shareholder at Polsinelli and Matt Bogle, Managing Director at Intrinsic, to examine key factors fueling and impeding healthcare services M&A deal volume. In a follow-up to our previously posted webinar wrap-up, we’re discussing the panelists’ perspectives on the different healthcare verticals, their headwinds/tailwinds and impact on the market. BEHAVIORAL HEALTH Although the Behavioral Healthcare (BHC) market saw a leading 44% surge in activity from 2024 to 2025, deal volume still trailed expectations given the... Read More »
Creative Deal Structures Required: Insights from McDermott Will & Schulte’s Healthcare Private Equity Miami Conference
Building on our initial overview of McDermott Will & Schulte’s Healthcare Private Equity Miami conference, we are taking a deeper dive into the key panels and strategic dialogues that defined the event. It should be noted that the media at the conference were bound by the Chatham House Rule, so we will refer to speakers anonymously. A common theme that ran through multiple panels was that the 2026 market is drastically different from the market environment of previous years. While most experts offered an optimistic outlook for the remainder of 2026 and into 2027, others countered with a more cautious perspective given the market’s struggles over the past year. ... Read More »
Key Takeaways from HPE Miami 2026
LevinPro HC’s Kate Humphrey and Ben Swett attended McDermott Will & Schulte’s Healthcare Private Equity Miami conference, which brought together healthcare leaders in a powerhouse summit on the sands of South Beach. For two days, industry experts and leaders moved beyond surface-level buzz and delved into the complexities of private equity in healthcare. Attendees engaged in conversations ranging from investors’ latest stance on AI to analyzing the hottest investment sectors. Here are our top takeaways: New Normal for Dealmaking A large portion of the conversations centered on a “new normal” for dealmaking, in which the market has shifted from the post-pandemic frenzy to a more... Read More »
February Freeze: Healthcare M&A Cools
Following a robust start in January, healthcare M&A volume declined notably in February. With 144 announced transactions, the deal volume for February 2026 is 40% lower than the 240 reported in January 2026, but marks a small decrease from the 150 announced in February 2025. Despite the decline in M&A volume, it is worth noting that February is historically a quiet month for deal activity and is following the trend; over the last five years, there has been an average of 150 deals reported throughout February. As with most months, most transactions were in the Physician Medical Group (PMG) sector, with 33 deals, accounting for 23% of activity. This is a 42% drop from the 57 PMG... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
